Interest Income Expense Net

Name: Syndax Pharmaceuticals Interest Income Expense Net by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Syndax Pharmaceuticals·Business Segments·1 segment·Rolls up to Net Interest Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$7.18M	$5.95M	-$5.27M	-$4.33M	-$3.56M
Total	—	—	—	—	—

Segments

Business SegmentsView metric